{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:05:43Z","timestamp":1788984343538,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770605"],"award-info":[{"award-number":["81770605"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300332"],"award-info":[{"award-number":["81300332"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005063","name":"Excellent Young Talents Fund Program of Higher Education Institutions of Anhui Province","doi-asserted-by":"publisher","award":["gxyqZD2018024"],"award-info":[{"award-number":["gxyqZD2018024"]}],"id":[{"id":"10.13039\/501100005063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatic fibrosis is a disease of the wound-healing response following chronic liver injury, and activated hepatic stellate cells (HSCs) play a crucial role in the progression of hepatic fibrosis. \u03b2-arrestin2 functions as a multiprotein scaffold to coordinate complex signal transduction networks. Although \u03b2-arrestin2 transduces diverse signals in cells, little is known about its involvement in the regulation of liver fibrosis. Our current study utilized a porcine serum-induced liver fibrosis model and found increased expression of \u03b2-arrestin2 in hepatic tissues with the progression of hepatic fibrosis, which was positively correlated with collagen levels. Furthermore, changes in human fibrotic samples were also observed. We next used \u03b2-arrestin2<jats:sup>\u2212\/\u2212<\/jats:sup> mice to demonstrate that \u03b2-arrestin2 deficiency ameliorates CCl<jats:sub>4<\/jats:sub>-induced liver fibrosis and decreases collagen deposition. The in vitro depletion and overexpression experiments showed that decreased \u03b2-arrestin2 inhibited HSCs collagen production and elevated T\u03b2RIII expression, thus downregulating the TGF-\u03b21 pathway components Smad2, Smad3 and Akt. These findings suggest that \u03b2-arrestin2 deficiency ameliorates liver fibrosis in mice, and \u03b2-arrestin2 may be a potential treatment target in hepatic fibrosis.<\/jats:p>","DOI":"10.1038\/s41419-020-2596-8","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T12:02:53Z","timestamp":1590062573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["\u03b2-arrestin2 deficiency protects against hepatic fibrosis in mice and prevents synthesis of extracellular matrix"],"prefix":"10.1038","volume":"11","author":[{"given":"Wu-Yi","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Jing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Chang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Jia","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,21]]},"reference":[{"key":"2596_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","volume":"68-69","author":"D Schuppan","year":"2018","unstructured":"Schuppan, D., Ashfaq-Khan, M., Yang, A. T. & Kim, Y. O. Liver fibrosis: Direct antifibrotic agents and targeted therapies. Matrix Biol. 68-69, 435\u2013451 (2018).","journal-title":"Matrix Biol."},{"key":"2596_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida, T. & Friedman, S. L. Mechanisms of hepatic stellate cell activation. Nat. Rev. Gastroenterol. Hepatol. 14, 397\u2013411 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2596_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.phrs.2014.05.005","volume":"85","author":"S Zhang","year":"2014","unstructured":"Zhang, S., Sun, W. Y., Wu, J. J. & Wei, W. TGF-beta signaling pathway as a pharmacological target in liver diseases. Pharmacol. Res. 85, 15\u201322 (2014).","journal-title":"Pharmacol. Res."},{"key":"2596_CR4","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cellsig.2018.09.002","volume":"52","author":"AA Vander","year":"2018","unstructured":"Vander, A. A., Cao, J. & Li, X. TGF-beta receptors: in and beyond TGF-beta signaling. Cell. Signal. 52, 112\u2013120 (2018).","journal-title":"Cell. Signal."},{"key":"2596_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1124\/pr.116.013367","volume":"69","author":"YK Peterson","year":"2017","unstructured":"Peterson, Y. K. & Luttrell, L. M. The diverse roles of arrestin scaffolds in G protein-coupled receptor signaling. Pharmacol. Rev. 69, 256\u2013297 (2017).","journal-title":"Pharmacol. Rev."},{"key":"2596_CR6","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s11033-012-2148-0","volume":"40","author":"S Hu","year":"2013","unstructured":"Hu, S. et al. Involvement of beta-arrestins in cancer progression. Mol. Biol. Rep. 40, 1065\u20131071 (2013).","journal-title":"Mol. Biol. Rep."},{"key":"2596_CR7","doi-asserted-by":"publisher","first-page":"35669","DOI":"10.1074\/jbc.M112.357871","volume":"287","author":"M Nakaya","year":"2012","unstructured":"Nakaya, M. et al. Induction of cardiac fibrosis by beta-blocker in G protein-independent and G protein-coupled receptor kinase 5\/beta-arrestin2-dependent signaling pathways. J. Biol. Chem. 287, 35669\u201335677 (2012).","journal-title":"J. Biol. Chem."},{"key":"2596_CR8","doi-asserted-by":"publisher","first-page":"74ra23","DOI":"10.1126\/scitranslmed.3001564","volume":"3","author":"AK Lovgren","year":"2011","unstructured":"Lovgren, A. K. et al. Beta-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix. Sci. Transl. Med. 3, 74ra23 (2011).","journal-title":"Sci. Transl. Med."},{"key":"2596_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00109-017-1606-5","volume":"96","author":"H Xu","year":"2018","unstructured":"Xu, H. et al. Beta-Arrestin-1 deficiency ameliorates renal interstitial fibrosis by blocking Wnt1\/beta-catenin signaling in mice. J. Mol. Med. (Berl.). 96, 97\u2013109 (2018).","journal-title":"J. Mol. Med. (Berl.)."},{"key":"2596_CR10","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/jcb.24458","volume":"114","author":"WY Sun","year":"2013","unstructured":"Sun, W. Y. et al. Depletion of beta-arrestin2 in hepatic stellate cells reduces cell proliferation via ERK pathway. J. Cell. Biochem. 114, 1153\u20131162 (2013).","journal-title":"J. Cell. Biochem."},{"key":"2596_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jhep.2017.02.025","volume":"67","author":"H Shen","year":"2017","unstructured":"Shen, H. et al. Thymic NF-kappaB-inducing kinase regulates CD4(+) T cell-elicited liver injury and fibrosis in mice. J. Hepatol. 67, 100\u2013109 (2017).","journal-title":"J. Hepatol."},{"key":"2596_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/B978-0-12-394440-5.00018-8","volume":"118","author":"LM Luttrell","year":"2013","unstructured":"Luttrell, L. M. Arrestin pathways as drug targets. Prog. Mol. Biol. Transl. Sci. 118, 469\u2013497 (2013).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"2596_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.intimp.2017.10.028","volume":"54","author":"F Bai","year":"2018","unstructured":"Bai, F. et al. Gypsophila elegans isoorientin-2\u201d-O-alpha-l-arabinopyranosyl ameliorates porcine serum-induced immune liver fibrosis by inhibiting NF-kappaB signaling pathway and suppressing HSC activation. Int. Immunopharmacol. 54, 60\u201367 (2018).","journal-title":"Int. Immunopharmacol."},{"key":"2596_CR14","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/aps.2015.74","volume":"36","author":"YJ Gu","year":"2015","unstructured":"Gu, Y. J., Sun, W. Y., Zhang, S., Wu, J. J. & Wei, W. The emerging roles of beta-arrestins in fibrotic diseases. Acta Pharmacol. Sin. 36, 1277\u20131287 (2015).","journal-title":"Acta Pharmacol. Sin."},{"key":"2596_CR15","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s11655-012-1146-3","volume":"18","author":"H Fan","year":"2012","unstructured":"Fan, H. et al. Role of beta2-adrenoceptor-beta-arrestin2-nuclear factor-kappaB signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis. Chin. J. Integr. Med. 18, 514\u2013521 (2012).","journal-title":"Chin. J. Integr. Med."},{"key":"2596_CR16","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1194\/jlr.M021972","volume":"53","author":"ME Manson","year":"2012","unstructured":"Manson, M. E., Corey, D. A., Bederman, I., Burgess, J. D. & Kelley, T. J. Regulatory role of beta-arrestin-2 in cholesterol processing in cystic fibrosis epithelial cells. J. Lipid Res. 53, 1268\u20131276 (2012).","journal-title":"J. Lipid Res."},{"key":"2596_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/cbf.3351","volume":"36","author":"K Mortezaee","year":"2018","unstructured":"Mortezaee, K. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: a review. Cell Biochem. Funct. 36, 292\u2013302 (2018).","journal-title":"Cell Biochem. Funct."},{"key":"2596_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2172-12-47","volume":"12","author":"Y Niu","year":"2011","unstructured":"Niu, Y. et al. The balance between intrahepatic IL-17(+) T cells and Foxp3(+) regulatory T cells plays an important role in HBV-related end-stage liver disease. BMC Immunol. 12, 47 (2011).","journal-title":"BMC Immunol."},{"key":"2596_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/cr.2009.138","volume":"20","author":"J Zhu","year":"2010","unstructured":"Zhu, J. & Paul, W. E. Heterogeneity and plasticity of T helper cells. Cell Res. 20, 4\u201312 (2010).","journal-title":"Cell Res."},{"key":"2596_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/imm.12720","volume":"151","author":"F Cachem","year":"2017","unstructured":"Cachem, F. et al. The proportion of different interleukin-17-producing T-cell subsets is associated with liver fibrosis in chronic hepatitis C. Immunology 151, 167\u2013176 (2017).","journal-title":"Immunology"},{"key":"2596_CR21","first-page":"171","volume":"10","author":"Y Liu","year":"2011","unstructured":"Liu, Y. et al. Beta-arrestin2 stimulates interleukin-17 production and expression of CD4+ T lymphocytes in a murine asthma model. Iran. J. Allergy Asthma Immunol. 10, 171\u2013182 (2011).","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"2596_CR22","doi-asserted-by":"publisher","first-page":"16660","DOI":"10.1073\/pnas.1208881109","volume":"109","author":"HL Nichols","year":"2012","unstructured":"Nichols, H. L. et al. Beta-Arrestin-2 mediates the proinflammatory effects of proteinase-activated receptor-2 in the airway. Proc. Natl Acad. Sci. USA 109, 16660\u201316665 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2596_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fphar.2017.00461","volume":"8","author":"KL Walton","year":"2017","unstructured":"Walton, K. L., Johnson, K. E. & Harrison, C. A. Targeting TGF-beta mediated SMAD signaling for the prevention of fibrosis. Front. Pharmacol. 8, 461 (2017).","journal-title":"Front. Pharmacol."},{"key":"2596_CR24","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/resp.13415","volume":"23","author":"AG Stewart","year":"2018","unstructured":"Stewart, A. G., Thomas, B. & Koff, J. TGF-beta: Master regulator of inflammation and fibrosis. Respirology 23, 1096\u20131097 (2018).","journal-title":"Respirology"},{"key":"2596_CR25","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.biopha.2010.01.006","volume":"64","author":"JY Ahn","year":"2010","unstructured":"Ahn, J. Y., Park, S., Yun, Y. S. & Song, J. Y. Inhibition of type III TGF-beta receptor aggravates lung fibrotic process. Biomed. Pharmacother. 64, 472\u2013476 (2010).","journal-title":"Biomed. Pharmacother."},{"key":"2596_CR26","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1158\/0008-5472.CAN-06-3117","volume":"67","author":"RS Turley","year":"2007","unstructured":"Turley, R. S. et al. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer. Cancer Res. 67, 1090\u20131098 (2007).","journal-title":"Cancer Res."},{"key":"2596_CR27","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.3892\/or.2016.4615","volume":"35","author":"S Zhang","year":"2016","unstructured":"Zhang, S., Sun, W. Y., Wu, J. J., Gu, Y. J. & Wei, W. Decreased expression of the type III TGF-beta receptor enhances metastasis and invasion in hepatocellullar carcinoma progression. Oncol. Rep. 35, 2373\u20132381 (2016).","journal-title":"Oncol. Rep."},{"key":"2596_CR28","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1126\/science.1083195","volume":"301","author":"W Chen","year":"2003","unstructured":"Chen, W. et al. Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. Science 301, 1394\u20131397 (2003).","journal-title":"Science"},{"key":"2596_CR29","doi-asserted-by":"publisher","first-page":"34808","DOI":"10.1074\/jbc.M804741200","volume":"283","author":"EC Finger","year":"2008","unstructured":"Finger, E. C., Lee, N. Y., You, H. J. & Blobe, G. C. Endocytosis of the type III transforming growth factor-beta (TGF-beta) receptor through the clathrin-independent\/lipid raft pathway regulates TGF-beta signaling and receptor down-regulation. J. Biol. Chem. 283, 34808\u201334818 (2008).","journal-title":"J. Biol. Chem."},{"key":"2596_CR30","doi-asserted-by":"publisher","first-page":"8221","DOI":"10.1073\/pnas.0812879106","volume":"106","author":"K Mythreye","year":"2009","unstructured":"Mythreye, K. & Blobe, G. C. The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42. Proc. Natl Acad. Sci. USA 106, 8221\u20138226 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2596_CR31","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1091\/mbc.E15-04-0203","volume":"26","author":"K Tazat","year":"2015","unstructured":"Tazat, K., Hector-Greene, M., Blobe, G. C. & Henis, Y. I. TbetaRIII independently binds type I and type II TGF-beta receptors to inhibit TGF-beta signaling. Mol. Biol. Cell. 26, 3535\u20133545 (2015).","journal-title":"Mol. Biol. Cell."},{"key":"2596_CR32","first-page":"878","volume":"34","author":"WY Sun","year":"2018","unstructured":"Sun, W. Y., Sun, J. C., Li, X. R., Peng, W. T. & Wei, W. Breeding and genotype identification of Arrb2 gene knockout mice. Chin. Pharmacol. Bull. 34, 878\u2013881 (2018).","journal-title":"Chin. Pharmacol. Bull."},{"key":"2596_CR33","first-page":"491","volume":"29","author":"WY Sun","year":"2012","unstructured":"Sun, W. Y., Wang, L., Liu, H., Li, X. & Wei, W. A standardized extract from Paeonia lactiflora and Astragalus membranaceus attenuates liver fibrosis induced by porcine serum in rats. Int. J. Mol. Med. 29, 491\u2013498 (2012).","journal-title":"Int. J. Mol. Med."},{"key":"2596_CR34","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3389\/fphar.2017.00980","volume":"8","author":"J Yang","year":"2017","unstructured":"Yang, J. et al. MicroRNA-145 increases the apoptosis of activated hepatic stellate cells induced by TRAIL through NF-kappaB signaling pathway. Front. Pharmacol. 8, 980 (2017).","journal-title":"Front. Pharmacol."},{"key":"2596_CR35","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-2275(20)32030-7","volume":"41","author":"S Vogel","year":"2000","unstructured":"Vogel, S. et al. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J. Lipid Res. 41, 882\u2013893 (2000).","journal-title":"J. Lipid Res."},{"key":"2596_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jcmgh.2018.09.005","volume":"7","author":"R Martin-Mateos","year":"2019","unstructured":"Martin-Mateos, R. et al. Enhancer of zeste homologue 2 inhibition attenuates TGF-beta dependent hepatic stellate cell activation and liver fibrosis. Cell Mol. Gastroenterol. Hepatol. 7, 197\u2013209 (2019).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"2596_CR37","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jep.2007.04.005","volume":"112","author":"WY Sun","year":"2007","unstructured":"Sun, W. Y., Wei, W., Wu, L., Gui, S. Y. & Wang, H. Effects and mechanisms of extract from Paeonia lactiflora and Astragalus membranaceus on liver fibrosis induced by carbon tetrachloride in rats. J. Ethnopharmacol. 112, 514\u2013523 (2007).","journal-title":"J. Ethnopharmacol."},{"key":"2596_CR38","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3892\/ijmm.2016.2692","volume":"38","author":"YJ Gu","year":"2016","unstructured":"Gu, Y. J., Sun, W. Y., Zhang, S., Li, X. R. & Wei, W. Targeted blockade of JAK\/STAT3 signaling inhibits proliferation, migration and collagen production as well as inducing the apoptosis of hepatic stellate cells. Int. J. Mol. Med. 38, 903\u2013911 (2016).","journal-title":"Int. J. Mol. Med."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2596-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2596-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2596-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:56:50Z","timestamp":1670252210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2596-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,21]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["2596"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2596-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,21]]},"assertion":[{"value":"10 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"389"}}